Physician profile
Conor Haas
NPI 1477124998
$308.02
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $62.33 · 2022: $57.03 · 2023: $99.69 · 2024: $88.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $188.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $96.97 | 2023-2024 | Rexulti |
| Pfizer INC. | $55.36 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $51.71 | 2021-2024 | Xarelto |
| Mylan Specialty L.P. | $16.27 | 2023 | Yupelri |
| Astrazeneca Pharmaceuticals LP | $16.03 | 2021 | |
| Lilly USA, LLC | $15.04 | 2024 | Zepbound |
| Chiesi USA, INC. | $15.02 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.47 | 2023 | Xifaxan |
| Edwards Lifesciences Corporation | $13.77 | 2021 | |
| Amgen INC. | $13.38 | 2023 | Otezla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Conor Haas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.